7Weinheimei CJ, Toeniskoetter PD, Conversano A, et al. Preteatmetn with buflomedil enhances ventricular function by reducing the dysfunctional area after transient corongry arrtery occlusion [J]. Cardiovasc Res, 1992,26(5):470 - 475.
3Wakayama K, Murakami M, Suzuki M,et a/.Ischemic symp- toms inducedby occlusion of the unilateral vertebral artery with head rotationtogether with contralateral vertebral case report[J].Neurol Sci, 2005,236(12) : 87-90.
4Cloud GC, Markus HS.Diagnosis and management of ver- tebral artery stenosis[J].QJM, 2003,96 ( 1 ) :27-54.
5Englert JM,Hanford LE,Kaminski N,et a/.A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis[J].Am J Pathol,2008,172(3) :583-591.
6Queisser MA, Kouri FM, K~nigshoff M,et a/.Loss of RAGE in pulmonary fibrosis: molecular relations to functional cha- nges in pulmonary cell types[J].Am J Respir Cell Mol Biol, 2008,39 (3) : 337-345.
7Satoh S,Toshima Y,Ikegaki I,et a/.Wide therapeutic time window for fasudil neuroprotection against ischemia-in- duced delayed neuronal death in gerbils[J].Brain Res, 2007, 1128( 1):175-180.
8Bereczki D, Fekete I.Vinpocetine for acute ischaemic str- oke[J].Cochrane Database Syst Rev, 2008,23 (1) : CD000480.
10Jovanovi6 ZB,Pavlovid AM, Pekmezovi6 T,et a/.Tran- scranial Doppler assessment of cerebral vasomotor reac- tivity in evaluating the effects of vinpocetine in cerebral small vessel disease:a pilot study[J].Ideggyogy Sz, 2013, 66(7-8) : 263-268.
